Journals / Journal of Clinical and Analytical Medicine / 2016 / Cilt: 7 - Sayı: 5

Hemofagositik Sendrom: Olgu Sunumu

Hemophagocytic Syndrome: A Case Report

Pages
737–739
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early diagnosis of hemophagocytic syndrome is of utmost importance, as a delay in diagnosis significantly worsens the prognosis, and treatment should be tailored to the underlying pathology

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hemophagocytic syndrome, a serious clinical condition accompanying systemic inflammatory disorders, is characterized by massive hypercytokinemia as a result of excessive activation and proliferation of T-lymphocytes and macrophages.
📊
Key Findings & Data:This article aims to remind clinicians of the hemophagocytic syndrome in the differential diagnosis of patients with fever, pancytopenia, and hepatosplenomegaly.
💡
Conclusion & Impact:Early diagnosis of hemophagocytic syndrome is of utmost importance, as a delay in diagnosis significantly worsens the prognosis, and treatment should be tailored to the underlying pathology
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hemophagocytic syndrome, a serious clinical condition accompanying systemic inflammatory disorders, is characterized by massive hypercytokinemia as a result of excessive activation and proliferation of T-lymphocytes and macrophages. This article aims to remind clinicians of the hemophagocytic syndrome in the differential diagnosis of patients with fever, pancytopenia, and hepatosplenomegaly. This condition can be highly fatal despite the administration of appropriate therapy. Early diagnosis of hemophagocytic syndrome is of utmost importance, as a delay in diagnosis significantly worsens the prognosis, and treatment should be tailored to the underlying pathology

Özet

Hemofagositik sendrom sistemik inflamatuvar bozukluklara eşlik eden T-lenfosit ve makrofajların aşırı aktivasyon ve proliferasyonu sonucu oluşan masif hipersitokinemi seyreden ciddi bir tablodur. Bu olgu sunumunda yüksek ateş ve halsizlikle başvuran hemofagositik sendromlu bir vakanın sunulması amaçlandı. Tedaviye rağmen mortalite yüksek olabilir. Erken tanının önemli olduğu tanıda gecikildiğinde prognozu son derece kötü olan hemofagositik sendromun tanısı mümkün olan en kısa sürede konulmalı, tedavisi ise altta yatan etiyolojiye göre yapılmalıdır

🔖

Cite This Article

ÇALTILI, Ç., ALTINBİLEK, E., ÖZTÜRK, D., KAVALCI, C. (2022). Hemofagositik Sendrom: Olgu Sunumu. Journal of Clinical and Analytical Medicine, Cilt: 7 - Sayı: 5, 737–739. https://ajindex.com/articles/560868

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Oren H, Gulen H, Ucar C, Duman M, Irken G. Successful treatment of infection associated Hemophagocytic Syndrome with intravenous immunglobulin. Turk J Haematol 2003;20(2):95-9.
  2. Dofoureg-Lagelouse R, Jabado N, Le Diest F, Stephan JL, Souillet G, Bruin M, et al. Linkage of familial Hemophagocytic Lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. Am J Hum Genet 1999;64(1):172-9.
  3. Henter JI, Elinder G, Ost A. Diagnostic guidelines for Hemophagocytic Lym- phohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18(1):29-33 Araj GF. Update on laboratory diagnosis of human Brucellosis. Int J Antimicrob Agents 2010; 36(Suppl 1):S12-7. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in Hemophagocytic Syn- drome. Am J Pediatr Hematol Oncol 1993;15(1):92-8.
  4. Henter JI, Arico M, Elinder G, Imashuku S, Janka G. Familial Hemophagocytic Lymphohistiocytosis. Primary Hemophagocytic Lymphohistiocytosis. Hematol On- col Clin North Am 1998;12(2):417-33.
  5. Su IJ, Wang CH, Cheng AL, Chen RL. Hemophagocytic syndrome in Ebstein-Barr Virus associated T-Lymphoproliferative disorders: Disease spectrum, pathogen- esis, and management. Leuk lymphoma 1995;19(5-6):401-6.
  6. Gritta J, Shinsaku I, Goran E, Marion S, Jan-Inge H. Infection and Mmalignancy- associated Haemophagocytic Lymphohistiocytosis. Haemato-Oncol Clin N Am 1998;12(2):435-44.
  7. Şahin OZ, Tekin F, Karasu Z, Nart D, Batur Y. Hemophagocytic syndrome and fulminant hepatic failure. Akademik Gastroenteroloji Dergisi 2005;4(3):190-2 How to cite this article: Öztürk D, Altınbilek E, Çaltılı Ç, Kavalcı C. Hemophagocytic Syndrome: A Case Re- port. J Clin Anal Med 2016;7(5): 737-9.